The potential of GLP-1RAs to reduce alcohol consumption in humans was first reported at a scientific conference in 2011.141 An RCT157 evaluated the effect of 26 weeks of once-weekly exenatide treatment on the frequency of heavy drinking days in patients diagnosed with AUD
GLP-1 GLP-1 1 Glucagon-like peptide-1 receptor agonist, GLP-1 GLP-1SU(2012)2DDP-4(2014, Brunton)(2020, Mouhayyar) (2021, Ard) (2017, Brundell)(2015, van Bloemendaal) (2021, Ard) (2014, Shah) (2018, Drucker) (2018, Zhao) (2016, Hayas)(2018, Hlscher)
GLP-1R is a core member of the G protein-coupled receptor family and is widely distributed on the surface of many human cells (Zheng et al., 2024)
A short routine can help: wash hands, prepare supplies, let alcohol dry, relax the area, inject steadily, and pause for the full device instruction time